{"log_id": 6499554742674360452, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 4.2e-05, "average": 0.997323, "min": 0.96801}, "location": {"width": 682, "top": 246, "height": 29, "left": 282}, "words": "紫杉醇安全性的持续监测还报告了偶见的小肠梗阻、肠穿孔、胰腺炎、缺血"}, {"probability": {"variance": 9.4e-05, "average": 0.997221, "min": 0.94282}, "location": {"width": 724, "top": 287, "height": 31, "left": 240}, "words": "性结肠炎、脱水、食管炎、便秘和腹水。在紫杉醇单药治疗和联合其他化疗药治"}, {"probability": {"variance": 2.3e-05, "average": 0.997013, "min": 0.982029}, "location": {"width": 724, "top": 329, "height": 31, "left": 239}, "words": "疗的患者中,即使联合使用GCSF,也偶有中性粒细胞减少性小肠结肠炎(盲肠"}, {"probability": {"variance": 3e-06, "average": 0.998081, "min": 0.995593}, "location": {"width": 106, "top": 372, "height": 25, "left": 240}, "words": "炎)的报道"}, {"probability": {"variance": 1.6e-05, "average": 0.997716, "min": 0.988919}, "location": {"width": 126, "top": 414, "height": 25, "left": 281}, "words": "注射部位反应"}, {"probability": {"variance": 2e-06, "average": 0.999143, "min": 0.991888}, "location": {"width": 679, "top": 454, "height": 28, "left": 283}, "words": "包括继发于外渗的反应在内的注射部位的反应,通常是轻度的,并且包括注"}, {"probability": {"variance": 2e-05, "average": 0.998169, "min": 0.977766}, "location": {"width": 724, "top": 494, "height": 31, "left": 238}, "words": "射部位的局部水肿、疼痛、硬化、红斑、压痛、皮肤变色、浮肿。与3小时输注"}, {"probability": {"variance": 3e-06, "average": 0.998719, "min": 0.991497}, "location": {"width": 723, "top": 534, "height": 33, "left": 239}, "words": "相比,这些反应在24小时输注时发生率更高。其他部位输注紫杉醇后造成的先"}, {"probability": {"variance": 2.6e-05, "average": 0.997774, "min": 0.972805}, "location": {"width": 543, "top": 578, "height": 26, "left": 238}, "words": "前外渗部位皮肤反应复发,称之为“记忆复苏”,也偶有报道"}, {"probability": {"variance": 0.000306, "average": 0.994772, "min": 0.906821}, "location": {"width": 662, "top": 616, "height": 33, "left": 278}, "words": "紫杉醇安全性的持续监测偶有报道更严重的事件,例如:静脉炎、蜂窝织炎"}, {"probability": {"variance": 9e-06, "average": 0.998432, "min": 0.984514}, "location": {"width": 724, "top": 659, "height": 29, "left": 237}, "words": "硬化、皮肤剥脱、坏死、纤维化。在部分病例中,注射部位皮肤反应可能在一个"}, {"probability": {"variance": 1.7e-05, "average": 0.99827, "min": 0.979429}, "location": {"width": 470, "top": 701, "height": 26, "left": 237}, "words": "长时间输注过程中,或者输注后1周或10天后发生"}, {"probability": {"variance": 2.4e-05, "average": 0.997515, "min": 0.978318}, "location": {"width": 682, "top": 741, "height": 30, "left": 278}, "words": "目前对于外渗没有特殊的治疗。为防止外渗,建议在输注过程中密切监测输"}, {"probability": {"variance": 3e-06, "average": 0.997937, "min": 0.994067}, "location": {"width": 213, "top": 783, "height": 24, "left": 234}, "words": "注部位可能发生的渗漏"}, {"probability": {"variance": 1e-05, "average": 0.998568, "min": 0.990298}, "location": {"width": 171, "top": 822, "height": 26, "left": 276}, "words": "其他临床不良反应"}, {"probability": {"variance": 0.000388, "average": 0.99317, "min": 0.892122}, "location": {"width": 682, "top": 862, "height": 32, "left": 277}, "words": "绝大多数患者(87%)可发生脱发。与紫杉醇相关的过敏反应引起的暂时性"}, {"probability": {"variance": 0.000353, "average": 0.994753, "min": 0.888416}, "location": {"width": 806, "top": 901, "height": 36, "left": 235}, "words": "皮肤改变也有报道,但是没有其他的皮肤毒性与紫杉醇治疗显著相关。指甲的改"}, {"probability": {"variance": 0.003739, "average": 0.980008, "min": 0.655421}, "location": {"width": 825, "top": 923, "height": 56, "left": 236}, "words": "变(色素沉着或甲床变色)并不常见(2%)。21%的患者有浮肿的报道其中"}, {"probability": {"variance": 0.006218, "average": 0.984237, "min": 0.531801}, "location": {"width": 691, "top": 988, "height": 27, "left": 244}, "words": "7%的患者先前没有浮肿);只有1%的患者浮肿严重,但没有人需要断治疗"}, {"probability": {"variance": 0.001925, "average": 0.984109, "min": 0.813956}, "location": {"width": 826, "top": 1019, "height": 39, "left": 233}, "words": "浮肿通常是局部的,并且与疾病相关。基线正常的患者在5%的疗程中会出现浮"}, {"probability": {"variance": 6.8e-05, "average": 0.996663, "min": 0.970291}, "location": {"width": 360, "top": 1070, "height": 25, "left": 233}, "words": "肿,并且在研究中没有随着时间而增加"}, {"probability": {"variance": 0.000182, "average": 0.995348, "min": 0.922815}, "location": {"width": 670, "top": 1109, "height": 30, "left": 287}, "words": "紫杉醇安全性的持续监测还包括偶有发生的辐射性记忆复苏有关的皮肤异"}, {"probability": {"variance": 6.3e-05, "average": 0.996459, "min": 0.957332}, "location": {"width": 724, "top": 1151, "height": 28, "left": 233}, "words": "常,斑丘疹、瘙痒、 Stevens- Johnson综合征、中毒性表皮坏死松解症等。紫杉醇"}, {"probability": {"variance": 7.4e-05, "average": 0.995113, "min": 0.965769}, "location": {"width": 741, "top": 1191, "height": 29, "left": 233}, "words": "安全性的持续监测还报道了偶见的结膜炎、流泪多、厌食、神志不清闪光幻"}, {"probability": {"variance": 1e-06, "average": 0.999014, "min": 0.995472}, "location": {"width": 338, "top": 1232, "height": 27, "left": 232}, "words": "眼前阴影、眩晕和血肌酐升高的报告"}, {"probability": {"variance": 0.002717, "average": 0.969774, "min": 0.879488}, "location": {"width": 163, "top": 1224, "height": 34, "left": 874}, "words": "华润广东"}, {"probability": {"variance": 0.01338, "average": 0.954722, "min": 0.471356}, "location": {"width": 785, "top": 1236, "height": 74, "left": 274}, "words": "紫杉醇安全性的持续监测报道的不良反应还包括乏力与不适。在紫杉醇剧"}, {"probability": {"variance": 0.020433, "average": 0.919996, "min": 0.354658}, "location": {"width": 813, "top": 1272, "height": 81, "left": 235}, "words": "15mgm24小时输注联合顺铂作为卵巢癌一线治疗的I期临床研光中17%的010"}, {"probability": {"variance": 0.00032, "average": 0.995347, "min": 0.90144}, "location": {"width": 565, "top": 1356, "height": 27, "left": 233}, "words": "患者出现乏力,明显高于环磷酰胺/顺铂对照治疗的10%发生率"}, {"probability": {"variance": 4.3e-05, "average": 0.995956, "min": 0.984602}, "location": {"width": 89, "top": 1397, "height": 27, "left": 273}, "words": "意外暴露"}, {"probability": {"variance": 3e-06, "average": 0.998986, "min": 0.99244}, "location": {"width": 672, "top": 1438, "height": 31, "left": 274}, "words": "吸入时,有呼吸困难、胸痛、眼部灼热、喉痛和恶心的报道。局部暴露后"}], "language": 3}